Announced
Completed
Financials
Sources
Tags
Private Equity
Domestic
Acquisition
Completed
Single Bidder
pathology services
Friendly
health care
Health Care Services
United States
Private
Majority
Synopsis
GTCR, a private equity firm, completed a $1.2bn investment in PathGroup, a premier provider of anatomic, clinical and molecular pathology services. "Dr. Davis and the PathGroup team have done an incredible job of building PathGroup into a unique, scaled lab services business with outstanding clinical services. We look forward to supporting the team and expanding the PathGroup platform through organic growth initiatives and additional strategic acquisitions," Sean Cunningham, GTCR Managing Director and Co-Head of Healthcare.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.